Evidence in postmortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophrenia

Diagnostic and Statistical Manual of Mental Disorders

Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,841 · see citing works

Progress in experimental personality research

Maher, W. B., & Maher, B. A. (1964) · Academic Press eBooks · Cited by 2,347 · see citing works

Molecular cloning, functional properties, and distribution of rat brain alpha 7: a nicotinic cation channel highly permeable to calcium

Séguéla, P., Wadiche, J. I., Dineley‐Miller, K., Dani, J., & Jw, P. (1993) · Journal of Neuroscience · doi:10.1523/jneurosci.13-02-00596.1993 · Cited by 1,471 · see citing works

Neurophysiological evidence for a defect in neuronal mechanisms involved in sensory gating in schizophrenia.

Adler, L. E., Pachtman, E., Franks, R. D., Pecevich, M., Waldo, M. C., & Freedman, R. (1982) · PubMed · Cited by 896 · see citing works

Deficits in Small Interneurons in Prefrontal and Cingulate Cortices of Schizophrenic and Schizoaffective Patients

Benes, F. M. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810350036005 · Cited by 894 · see citing works

Basal Ganglia and Limbic System Pathology in Schizophrenia: A Morphometric Study of Brain Volume and Shrinkage

Bogerts, B. (1985) · Archives of General Psychiatry · doi:10.1001/archpsyc.1985.01790310046006 · Cited by 880 · see citing works

A subtype of nicotinic cholinergic receptor in rat brain is composed of alpha 4 and beta 2 subunits and is up-regulated by chronic nicotine treatment.

Flores, C. M., Rogers, S. W., Pabreza, L. A., Wolfe, B. B., & Kellar, K. J. (1992) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)08832-7 · Cited by 880 · see citing works

Cigarette smoking: implications for psychiatric illness

(1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.4.546 · Cited by 723 · see citing works

Normalization of auditory physiology by cigarette smoking in schizophrenic patients

Adler, L. E., Hoffer, L., Wiser, A., & Freedman, R. (1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.12.1856 · Cited by 679 · see citing works

Cigarette smoking in schizophrenia: relationship to psychopathology and medication side effects

GOFF, D. C., Henderson, D. C., & Amico, E. (1992) · American Journal of Psychiatry · doi:10.1176/ajp.149.9.1189 · Cited by 576 · see citing works

Evidence that Tobacco Smoking Increases the Density of (−)‐[³H]Nicotine Binding Sites in Human Brain

Benwell, M. E. M., Balfour, D. J. K., & Anderson, J. M. (1988) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1988.tb10600.x · Cited by 551 · see citing works

Mutations in the channel domain alter desensitization of a neuronal nicotinic receptor

Revah, F., Bertrand, D., Galzi, J., Devillers‐Thiéry, A., Mulle, C., Hussy, N., Bertrand, S., Ballivet, M., & Changeux, J. (1991) · Nature · doi:10.1038/353846a0 · Cited by 524 · see citing works

Brain α-bungarotoxin binding protein cDNAs and MAbs reveal subtypes of this branch of the ligand-gated ion channel gene superfamily

Schoepfer, R., Conroy, W. G., Whiting, P. J., Gore, M., & Lindstrom, J. M. (1990) · Neuron · doi:10.1016/0896-6273(90)90031-a · Cited by 473 · see citing works

INPUT DYSFUNCTION IN SCHIZOPHRENIA.

Ph, V. (1964) · PubMed · Cited by 473 · see citing works

Distorted Distribution of Nicotinamide-Adenine Dinucleotide Phosphate—Diaphorase Neurons in Temporal Lobe of Schizophrenics Implies Anomalous Cortical Development

Akbarian, S. (1993) · Archives of General Psychiatry · doi:10.1001/archpsyc.1993.01820150016002 · Cited by 456 · see citing works

Hippocampal Pathologic Findings in Schizophrenia

Jeste, D. V. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810110061009 · Cited by 427 · see citing works

Normalization by nicotine of deficient auditory sensory gating in the relatives of schizophrenics

Adler, L. E., Hoffer, L., Griffith, J. M., Waldo, M. C., & Freedman, R. (1992) · Biological Psychiatry · doi:10.1016/0006-3223(92)90073-9 · Cited by 412 · see citing works

Functional Organization of the Limbic System in the Process of Registration of Information: Facts and Hypotheses

Vinogradova, O. S. (1975) · Springer eBooks · doi:10.1007/978-1-4684-2979-4_1 · Cited by 335 · see citing works

Reduced Neuronal Size in Posterior Hippocampus of Schizophrenic Patients

Benes, F. M., Sorensen, I., & Bird, E. D. (1991) · Schizophrenia Bulletin · doi:10.1093/schbul/17.4.597 · Cited by 279 · see citing works

Nicotinic receptors that bind α-bungarotoxin on neurons raise intracellular free ca2+

Vijayaraghavan, S., Pugh, P. C., Zhang, Z., Rathouz, M. M., & Berg, D. K. (1992) · Neuron · doi:10.1016/0896-6273(92)90301-s · Cited by 264 · see citing works

Sensory gating deficits in schizophrenia: new results

Judd, L. L., McAdams, L. A., Budnick, B., & BRAFF, D. L. (1992) · American Journal of Psychiatry · doi:10.1176/ajp.149.4.488 · Cited by 263 · see citing works

Cholinergic gating of response to auditory stimuli in rat hippocampus

Luntz‐Leybman, V., Bickford, P. C., & Freedman, R. (1992) · Brain Research · doi:10.1016/0006-8993(92)91437-j · Cited by 260 · see citing works

Parasympathetic Suppression of Manic Symptoms by Physostigmine

Janowsky, D. S. (1973) · Archives of General Psychiatry · doi:10.1001/archpsyc.1973.01750340072012 · Cited by 225 · see citing works

Neurons in rat hippocampus that synthesize nitric oxide

Valtschanoff, J. G., Weinberg, R., Kharazia, V., Nakane, M., & Schmidt, H. (1993) · The Journal of comparative neurology · doi:10.1002/cne.903310107 · Cited by 219 · see citing works

Homomers of alpha 8 and alpha 7 subunits of nicotinic receptors exhibit similar channel but contrasting binding site properties.

Gerzanich, V., Anand, R., & Lindstrom, J. M. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09916-x · Cited by 218 · see citing works

Brain Acetylcholine and Neuropsychiatric Disease

Davis, K. L., & Berger, P. A. (1979) · Springer eBooks · doi:10.1007/978-1-4613-2934-3 · Cited by 210 · see citing works

Alpha-bungarotoxin binding to hippocampal interneurons: immunocytochemical characterization and effects on growth factor expression

Freedman, R., Wetmore, C., Strömberg, I., Leonard, S. S., & Olson, L. (1993) · Journal of Neuroscience · doi:10.1523/jneurosci.13-05-01965.1993 · Cited by 202 · see citing works

Deficit and hemispheric asymmetry of GABA uptake sites in the hippocampus in schizophrenia

Reynolds, G. P., Czudek, C., & Andrews, H. B. (1990) · Biological Psychiatry · doi:10.1016/0006-3223(90)90039-5 · Cited by 201 · see citing works

Smoking and Malignancy in Schizophrenia

Masterson, E. L., & O’Shea, B. (1984) · The British Journal of Psychiatry · doi:10.1192/bjp.145.4.429 · Cited by 155 · see citing works

Nicotine receptors in the mammalian brain

Luetje, C. W., Patrick, J., & Séguéla, P. (1990) · The FASEB Journal · doi:10.1096/fasebj.4.10.2197155 · Cited by 147 · see citing works

Nicotinic acetylcholine receptor subtypes in human frontal cortex: Changes in Alzheimer's disease

Sugaya, K., Giacobini, E., & Chiappinelli, V. A. (1990) · Journal of Neuroscience Research · doi:10.1002/jnr.490270314 · Cited by 144 · see citing works

Presynaptic Nicotinic Receptors and the Modulation of Transmitter Release

Wonnacott, S., Drasdo, A. L., Sanderson, E. M., & Rowell, P. P. (2007) · Novartis Foundation symposium · doi:10.1002/9780470513965.ch6 · Cited by 128 · see citing works

Homomeric and native α7 acetylcholine receptors exhibit remarkably similar but non‐identical pharmacological properties, suggesting that the native receptor is a heteromeric protein complex

Anand, R., Peng, X.-D., & Lindstrom, J. M. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)80177-v · Cited by 126 · see citing works

Physostigmine ameliorates the delusions of Alzheimer's disease

Cummings, J. L., Gorman, D. G., & Shapira, J. S. (1993) · Biological Psychiatry · doi:10.1016/0006-3223(93)90009-3 · Cited by 125 · see citing works

Cholinergic receptor binding and autoradiography in brains of non-neurological and senile dementia of Alzheimer-type patients

Lang, W., & Henke, H. (1983) · Brain Research · doi:10.1016/0006-8993(83)90879-x · Cited by 124 · see citing works

Neurophysiologic studies of sensory gating in schizophrenia: Comparison of auditory and visual responses

Adler, L. E., Waldo, M. C., & Freedman, R. (1985) · Biological Psychiatry · doi:10.1016/0006-3223(85)90113-1 · Cited by 120 · see citing works

Choline acetyltransferase in schizophrenia

Karson, C. N., Casanova, M. F., Kleinman, J. E., & Griffin, W. S. T. (1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.3.454 · Cited by 106 · see citing works

Molecular Cloning and Chromosomal Localization of the Human α7-Nicotinic Receptor Subunit Gene (CHRNA7)

Chini, B., Raimond, E., Elgoyhen, A. B., Moralli, D., Balzaretti, M., & Heinemann, S. (1994) · Genomics · doi:10.1006/geno.1994.1075 · Cited by 99 · see citing works

Postmortem stability of α-bungarotoxin binding sites in mouse and human brain

Davies, P., & Feisullin, S. (1981) · Brain Research · doi:10.1016/0006-8993(81)90148-7 · Cited by 99 · see citing works

Distribution of nicotinic cholinergic receptors in the rat tel‐ and diencephalon: a quantitative receptor autoradiographical study using [3H]‐acetylcholine, [α‐125l]bungarotoxin and [3H]nicotine

Härfstrand, A., Adem, A., Fuxé, K., Agnati, L. F., Andersson, K., & Nordberg, A. K. (1988) · Acta Physiologica Scandinavica · doi:10.1111/j.1748-1716.1988.tb08291.x · Cited by 93 · see citing works

[125I]α-Bungarotoxin binding marks primary sensory areas of developing rat neocortex

Fuchs, J. L. (1989) · Brain Research · doi:10.1016/0006-8993(89)90640-9 · Cited by 74 · see citing works

Physiological Aspects of Visual Perception

Denny-Brown, D. E. (1976) · Archives of Neurology · doi:10.1001/archneur.1976.00500040012003 · Cited by 72 · see citing works

Selective antagonism of nicotine actions in the rat cerebellum with α-bungarotoxin

de la Garza, R., McGuire, T. J., Freedman, R., & Hoffer, B. J. (1987) · Neuroscience · doi:10.1016/0306-4522(87)90165-5 · Cited by 66 · see citing works

Characterization of [3H]cytisine binding to human brain membrane preparations

Hall, M., Zerbe, L., Leonard, S., & Freedman, R. (1993) · Brain Research · doi:10.1016/0006-8993(93)90410-o · Cited by 64 · see citing works

Use of a neurophysiological trait in linkage analysis of schizophrenia

Coon, H. H., Plaetke, R., Holik, J., Hoff, M., Myles‐Worsley, M., Waldo, M., Freedman, R., & Byerley, W. (1993) · Biological Psychiatry · doi:10.1016/0006-3223(93)90085-r · Cited by 55 · see citing works

Increased muscarinic cholinergic receptors in prefrontal cortices of medicated schizophrenics

Watanabe, S., Nishikawa, T., Takashima, M., & Toru, M. (1983) · Life Sciences · doi:10.1016/0024-3205(83)90290-4 · Cited by 54 · see citing works

The nucleus basalis of Meynert, senile plaques, and intellectual impairment in schizophrenia

El‐Mallakh, R. S., Kirch, D. G., Shelton, R. C., Fan, K. J., Pezeshkpour, G. H., Kanhouwa, S., Wyatt, R. J., & Kleinman, J. E. (1991) · Journal of Neuropsychiatry · doi:10.1176/jnp.3.4.383 · Cited by 50 · see citing works

Autoradiographic distribution of [3H]nicotine binding in human cortex: Relative abundance in subicular complex

Perry, E. K., COURT, J. A., Johnson, M., Piggott, M. A., & Perry, R. H. (1992) · Journal of Chemical Neuroanatomy · doi:10.1016/0891-0618(92)90056-v · Cited by 47 · see citing works

Physiological Aspects of Visual Perception

Goldberg, M. E. (1976) · Archives of Neurology · doi:10.1001/archneur.1976.00500100063020 · Cited by 39 · see citing works

Normalization of auditory sensory gating in schizophrenic patients after a brief period for sleep

Griffith, J. M., Waldo, M. C., Adler, L. E., & Freedman, R. (1993) · Psychiatry Research · doi:10.1016/0165-1781(93)90028-f · Cited by 33 · see citing works

SENSITIVITY OF SKELETAL MUSCLE TO INTRA-ARTERIAL ACETYLCHOLINE IN NORMAL AND MYASTHENIC MAN

Acheson, G. H., Langohr, J. L., & Stanbury, J. B. (1948) · Journal of Clinical Investigation · doi:10.1172/jci101988 · Cited by 13 · see citing works

Chapter 9 α-Bungarotoxin receptors in the CNS

Morley, B. J. (1989) · Progress in brain research · doi:10.1016/s0079-6123(08)62469-3 · Cited by 9 · see citing works

Normalization of auditory sensory gating in schizophrenics after a brief period for sleep

Griffith, J. M., Waldo, M., Adler, L. E., & Freedman, R. (1993) · Schizophrenia Research · doi:10.1016/0920-9964(93)90289-u · Cited by 9 · see citing works

α‐Bungarotoxin interacts with the rat brain tachykinin receptors

Utkin, Y. N., Lazakovich, E. M., Kasheverov, I. E., & Tsetlin, V. I. (1989) · FEBS Letters · doi:10.1016/0014-5793(89)81071-3 · Cited by 8 · see citing works

Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence

Harrison, P. J., & Weinberger, D. R. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001558 · Cited by 2,020 · see citing works

Neuregulin 1 and Susceptibility to Schizophrenia

Stefánsson, H., Pétursson, H., Sigurðsson, E., Steinthórsdóttir, V., Bjornsdottir, S., Sigmundsson, T., Ghosh, S., Brynjolfsson, J., Gunnarsdottir, S., Ivarsson, O., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/342734 · Cited by 1,671 · see citing works

Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus

Freedman, R., Coon, H., Myles-Worsley, M., Orr-Urtreger, A., Olincy, A., Davis, A., Polymeropoulos, M., Holik, J., Hopkins, J., Hoff, M., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.2.587 · Cited by 1,141 · see citing works

Neuronal nicotinic receptors: from structure to pathology

Gotti, C., & Clementi, F. (2004) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2004.09.006 · Cited by 970 · see citing works

Neuronal nicotinic receptors in the human brain

Paterson, D., & Nordberg, A. K. (2000) · Progress in Neurobiology · doi:10.1016/s0301-0082(99)00045-3 · Cited by 782 · see citing works

Nicotinic receptors: allosteric transitions and therapeutic targets in the nervous system

Taly, A., Corringer, P., Guédin, D., Lestage, P. J., & Changeux, J. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2927 · Cited by 706 · see citing works

Schizophrenia, sensory gating, and nicotinic receptors

Adler, L. E., Olincy, A., Waldo, M., Harris, J. G., Griffith, J., Stevens, K., Flach, K., Nagamoto, H., Bickford, P., Leonard, S., et al. (1998) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a033320 · Cited by 690 · see citing works

Nicotinic acetylcholine involvement in cognitive function in animals

Levin, E. D., & Simon, B. B. (1998) · Psychopharmacology · doi:10.1007/s002130050667 · Cited by 675 · see citing works

The Hippocampal Formation in Schizophrenia

Tamminga, C. A., Stan, A. D., & Wagner, A. D. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.09081187 · Cited by 583 · see citing works

Neurophysiological Endophenotypes of Schizophrenia: The Viability of Selected Candidate Measures

Turetsky, B. I., Calkins, M. E., Light, G. A., D, A. O. M., Radant, A. D., & Swerdlow, N. R. (2006) · Schizophrenia Bulletin · doi:10.1093/schbul/sbl060 · Cited by 563 · see citing works

Nicotinic acetylcholine receptors: From basic science to therapeutics

Hurst, R. S., Rollema, H., & Bertrand, D. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.08.012 · Cited by 525 · see citing works

Nicotinic acetylcholine receptors: from structure to brain function

Hogg, R. C., Raggenbass, M., & Bertrand, D. (2003) · Springer eBooks · doi:10.1007/s10254-003-0005-1 · Cited by 529 · see citing works

Proof-of-Concept Trial of an α7 Nicotinic Agonist in Schizophrenia

D, A. O. M., Harris, J. G., Johnson, L. L., Pender, V., Kongs, S., Allensworth, D., Ellis, J., Zerbe, G. O., Leonard, S. S., Stevens, K. E., et al. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.6.630 · Cited by 531 · see citing works

Cognitive effects of nicotine

Rezvani, A. H., & Levin, E. D. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01094-5 · Cited by 519 · see citing works

Nicotine Dependence in Schizophrenia: Clinical Phenomena and Laboratory Findings

Dalack, G. W., Healy, D. J., & Meador‐Woodruff, J. H. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.11.1490 · Cited by 498 · see citing works

Nicotine use in schizophrenia: The self medication hypotheses

Kumari, V., & Postma, P. (2005) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.02.006 · Cited by 470 · see citing works

Nicotinic acetylcholine receptors in health and disease

Lindstrom, J. (1997) · Molecular Neurobiology · doi:10.1007/bf02740634 · Cited by 443 · see citing works

A Novel Positive Allosteric Modulator of the α7 Neuronal Nicotinic Acetylcholine Receptor:In VitroandIn VivoCharacterization

Hurst, R. S., Hajós, M., Raggenbass, M., Wall, T. M., Higdon, N. R., Lawson, J. A., Rutherford-Root, K. L., Berkenpas, M. B., Hoffmann, W. E., Piotrowski, D. W., et al. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.5269-04.2005 · Cited by 447 · see citing works

Association of Promoter Variants in the α7 Nicotinic Acetylcholine Receptor Subunit Gene With an Inhibitory Deficit Found in Schizophrenia

Leonard, S. S., Gault, J., Hopkins, J., Logel, J., Vianzon, R., Short, M., Drebing, C. J., Berger, R., Venn, D., Sirota, P., et al. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.12.1085 · Cited by 443 · see citing works

Initial phase 2 trial of a nicotinic agonist in schizophrenia

Freedman, R., Olincy, A., Buchanan, R. W., Harris, J. G., Gold, J. M., Johnson, L., Allensworth, D., Guzman-Bonilla, A., Clement, B., Ball, M. P., et al. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.07071135 · Cited by 426 · see citing works

Cognitive Effects of Nicotine

Sofouglu, M., Herman, A. I., Robinson, C. D., & Waters, A. J. (2014) · Lincoln (University of Nebraska) · Cited by 417 · see citing works

Human neuronal nicotinic receptors

Gotti, C., Fornasari, D., & Clementi, F. (1997) · Progress in Neurobiology · doi:10.1016/s0301-0082(97)00034-8 · Cited by 413 · see citing works

Effects of nicotinic stimulation on cognitive performance

NEWHOUSE, P. A. (2003) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2003.11.001 · Cited by 401 · see citing works

Sensory Processing Dysfunction in the Personal Experience and Neuronal Machinery of Schizophrenia

Javitt, D. C., & Freedman, R. (2015) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2014.13121691 · Cited by 403 · see citing works

Cholinergic Activity in Autism: Abnormalities in the Cerebral Cortex and Basal Forebrain

Perry, E. K., Lee, M., Martin-Ruiz, C. M., COURT, J. A., Volsen, S. G., Merrit, J., Folly, E. A., Iversen, P. E., Bauman, M. L., Perry, R. H., et al. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.7.1058 · Cited by 390 · see citing works

Neuregulin 1-erbB signaling and the molecular/cellular basis of schizophrenia

Corfas, G., Roy, K., & Buxbaum, J. D. (2004) · Nature Neuroscience · doi:10.1038/nn1258 · Cited by 388 · see citing works

Addressing tobacco among individuals with a mental illness or an addiction

Williams, J. M., & Ziedonis, D. M. (2004) · Addictive Behaviors · doi:10.1016/j.addbeh.2004.03.009 · Cited by 356 · see citing works

Nicotinic receptors in the brain. Links between molecular biology and behavior

Picciotto, M. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00146-3 · Cited by 354 · see citing works

Abnormal Regulation of High Affinity Nicotinic Receptors in Subjects with Schizophrenia

Breese, C. R. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00121-4 · Cited by 343 · see citing works

Alpha-7 nicotinic receptor agonists: potential new candidates for the treatment of schizophrenia

Martin, L., Kem, W., & Freedman, R. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1750-1 · Cited by 340 · see citing works

Muscle and neuronal nicotinic acetylcholine receptors

Kalamida, D., Poulas, K. A., Avramopoulou, V., Fostieri, E., Lagoumintzis, G., Lazaridis, K., Sideri, A., Zouridakis, M., & Tzartos, S. J. (2007) · FEBS Journal · doi:10.1111/j.1742-4658.2007.05935.x · Cited by 334 · see citing works

Smoking and mental illness

Leonard, S. S., Adler, L. E., Benhammou, K., Berger, R., Breese, C. R., Drebing, C. J., Gault, J., Lee, M. J., Logel, J., D, A. O. M., et al. (2001) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00677-3 · Cited by 298 · see citing works

Cognitive Effects of Nicotine: Recent Progress

Valentine, G. W., & Sofuoglu, M. (2017) · Current Neuropharmacology · doi:10.2174/1570159x15666171103152136 · Cited by 280 · see citing works

Nicotinic Receptor Function in Schizophrenia

Leonard, S. S., Adams, C., Breese, C. R., Adler, L. E., Bickford, P. C., Byerley, W., Coon, H. H., Griffith, J. M., Miller, C., Myles‐Worsley, M., et al. (1996) · Schizophrenia Bulletin · doi:10.1093/schbul/22.3.431 · Cited by 263 · see citing works

Acetylcholine–Dopamine Interactions in the Pathophysiology and Treatment of CNS Disorders

Lester, D. B., Rogers, T. D., & Blaha, C. D. (2010) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2010.00142.x · Cited by 260 · see citing works

Neuronal Nicotinic Receptors in Dementia with Lewy Bodies and Schizophrenia

COURT, J. A., Spurden, D., Lloyd, S. R., McKeith, I. G., Ballard, C. G., Cairns, N. J., Kerwin, R. W., Perry, R., & Perry, E. K. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0731590.x · Cited by 252 · see citing works

Increased levels of the nicotine metabolite cotinine in schizophrenic smokers compared to other smokers

D, A. O. M., Young, D. A., & Freedman, R. (1997) · Biological Psychiatry · doi:10.1016/s0006-3223(96)00302-2 · Cited by 252 · see citing works

Pharmacological treatment effects on eye movement control

Reilly, J. L., Lencer, R., Bishop, J. R., Keedy, S., & Sweeney, J. A. (2008) · Brain and Cognition · doi:10.1016/j.bandc.2008.08.026 · Cited by 248 · see citing works

Genomic Organization and Partial Duplication of the Human α7 Neuronal Nicotinic Acetylcholine Receptor Gene (CHRNA7)

Gault, J., Robinson, M., Berger, R., Drebing, C. J., Logel, J., Hopkins, J., Moore, T., Jacobs, S., Meriwether, J., Choi, M. J., et al. (1998) · Genomics · doi:10.1006/geno.1998.5363 · Cited by 245 · see citing works

Inhibitory Gating of an Evoked Response to Repeated Auditory Stimuli in Schizophrenic and Normal Subjects

Freedman, R. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830120052009 · Cited by 246 · see citing works

Why do patients with schizophrenia smoke?

Winterer, G. (2010) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e3283366643 · Cited by 238 · see citing works

The Effects of Transdermal Nicotine on Cognition in Nonsmokers with Schizophrenia and Nonpsychiatric Controls

Barr, R. S., Maravić, M. C., Jubelt, L. E., Mufti, R. S., Dyer, M. A., Weiss, A. P., Deckersbach, T., Kelly, J. F., Freudenreich, O., GOFF, D. C., et al. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301423 · Cited by 238 · see citing works

Effects of Nicotine on Cognitive Deficits in Schizophrenia

Harris, J. G., Kongs, S., Allensworth, D., Martín, L., Tregellas, J. R., Sullivan, B. F., Zerbe, G. O., & Freedman, R. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300450 · Cited by 235 · see citing works

Gene Expression Profile for Schizophrenia

Hemby, S. E., Ginsberg, S. D., Brunk, B. P., Arnold, S. E., Trojanowski, J. Q., & Eberwine, J. H. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.7.631 · Cited by 234 · see citing works

Impaired attention is central to the cognitive deficits observed in alpha 7 deficient mice

Young, J. W., Crawford, N., Kelly, J. S., Kerr, L. E., Marston, H. M., Spratt, C., Finlayson, K., & Sharkey, J. (2007) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2006.03.008 · Cited by 233 · see citing works

Nicotine effects on brain function and functional connectivity in schizophrenia

Jacobsen, L. K., D’Souza, D. C., Mencl, W. E., Pugh, K. R., Skudlarski, P., & Krystal, J. H. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2003.12.023 · Cited by 233 · see citing works

Muscarinic and Nicotinic Acetylcholine Receptor Agonists and Allosteric Modulators for the Treatment of Schizophrenia

Jones, C. K., Byun, N. E., & Bubser, M. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.199 · Cited by 228 · see citing works

Molecular Targets for Treating Cognitive Dysfunction in Schizophrenia

Gray, J. A., & Roth, B. L. (2007) · Schizophrenia Bulletin · doi:10.1093/schbul/sbm074 · Cited by 225 · see citing works

Targeting the nicotinic alpha7 acetylcholine receptor to enhance cognition in disease

Wallace, T. L., & Porter, R. H. P. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.06.034 · Cited by 225 · see citing works

Neuronal nicotinic acetylcholine receptor subunit knockout mice: physiological and behavioral phenotypes and possible clinical implications

Picciotto, M. R., Caldarone, B. J., Brunzell, D. H., Zachariou, V., Stevens, T. R., & King, S. L. (2001) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(01)00161-9 · Cited by 221 · see citing works

Smoking, nicotine and neuropsychiatric disorders

Döme, P., Lazáry, J., Kalapos, M. P., & Rihmer, Z. (2009) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2009.07.013 · Cited by 215 · see citing works

An Allosteric Modulator of the α7 Nicotinic Acetylcholine Receptor Possessing Cognition-Enhancing Properties in Vivo

Timmermann, D. B., Grønlien, J. H., Kohlhaas, K. L., Nielsen, E. Ø., Dam, E., Dyhring, T., Ahring, P. K., Peters, D., Holst, D., Chrsitensen, J. K., et al. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.120436 · Cited by 217 · see citing works

The Neurobiology of Autism

Bauman, M. L. (2006) · Johns Hopkins University Press eBooks · doi:10.1353/book.3225 · Cited by 215 · see citing works

The α7-nicotinic acetylcholine receptor and the pathology of hippocampal interneurons in schizophrenia

Freedman, R., Adams, C. E., & Leonard, S. S. (2000) · Journal of Chemical Neuroanatomy · doi:10.1016/s0891-0618(00)00109-5 · Cited by 212 · see citing works

Schizophrenia and the α7 Nicotinic Acetylcholine Receptor

Martin, L. F., & Freedman, R. (2007) · International Review of Neurobiology · doi:10.1016/s0074-7742(06)78008-4 · Cited by 213 · see citing works

Genetic Correlation of Inhibitory Gating of Hippocampal Auditory Evoked Response and α-Bungarotoxin-Binding Nicotinic Cholinergic Receptors in Inbred Mouse Strains

Stevens, K. E. (1996) · Neuropsychopharmacology · doi:10.1016/0893-133x(95)00178-g · Cited by 203 · see citing works

The treatment of cognitive impairment in schizophrenia

GOFF, D. C., Hill, M. B., & Barch, D. M. (2010) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2010.11.009 · Cited by 196 · see citing works

Discovery ofN-[(3R)-1-Azabicyclo[2.2.2]oct-3-yl]furo[2,3-c]pyridine-5-carboxamide, an Agonist of the α7 Nicotinic Acetylcholine Receptor, for the Potential Treatment of Cognitive Deficits in Schizophrenia: Synthesis and Structure−Activity Relationship

Wishka, D. G., Walker, D. P., Yates, K. M., Reitz, S. C., Jia, S., Myers, J. K., Olson, K. L., Jacobsen, E. J., Wolfe, M. L., Groppi, V. E., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0602413 · Cited by 194 · see citing works

A pilot trial of bupropion added to cognitive behavioral therapy for smoking cessation in schizophrenia

Evins, A. E., Mays, V. K., Rigotti, N. A., Tisdale, T., Cather, C., & Goff, D. C. (2001) · Nicotine & Tobacco Research · doi:10.1080/14622200110073920 · Cited by 191 · see citing works

Wnt Signaling: Role in Alzheimer Disease and Schizophrenia

Inestrosa, N. C., Montecinos-Oliva, C., & Fuenzalida, M. (2012) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-012-9417-5 · Cited by 186 · see citing works

The human CHRNA7 and CHRFAM7A genes: A review of the genetics, regulation, and function

Sinkus, M. L., Graw, S. L., Freedman, R., Ross, R. G., Lester, H. A., & Leonard, S. S. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.02.006 · Cited by 186 · see citing works

Effects of transcranial direct current stimulation (tDCS) on cognition, symptoms, and smoking in schizophrenia: A randomized controlled study

Smith, R. C., Boules, S., Mattiuz, S., Youssef, M., Tobe, R. H., Sershen, H. W., Lajtha, Á., Nolan, K. A., Amiaz, R., & Davis, J. M. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.06.011 · Cited by 187 · see citing works

Cholinergic targets for cognitive enhancement in schizophrenia: focus on cholinesterase inhibitors and muscarinic agonists

Friedman, J. I. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1794-x · Cited by 183 · see citing works

Modulatory effects of α7 nAChRs on the immune system and its relevance for CNS disorders

Kalkman, H. O., & Feuerbach, D. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2175-4 · Cited by 182 · see citing works

Nicotinic receptors in human brain: topography and pathology

Court, J. A., Martin-Ruiz, C., Graham, A., & Perry, E. (2000) · Journal of Chemical Neuroanatomy · doi:10.1016/s0891-0618(00)00110-1 · Cited by 180 · see citing works

A 12-Week Double-Blind, Placebo-Controlled Study of Bupropion SR Added to High-Dose Dual Nicotine Replacement Therapy for Smoking Cessation or Reduction in Schizophrenia

Evins, A. E., Cather, C., Culhane, M. A., Birnbaum, A., Horowitz, J., Hsieh, E., Freudenreich, O., Henderson, D. C., Schoenfeld, D. A., Rigotti, N. A., et al. (2007) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0b013e3180ca86fa · Cited by 179 · see citing works

Smoking and schizophrenia: abnormal nicotinic receptor expression

Leonard, S., Breese, C., Adams, C., Benhammou, K., Gault, J., Stevens, K., Lee, M., Adler, L., Olincy, A., Ross, R., et al. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00035-2 · Cited by 177 · see citing works

A Randomized Exploratory Trial of an Alpha-7 Nicotinic Receptor Agonist (TC-5619) for Cognitive Enhancement in Schizophrenia

Lieberman, J. A., Dunbar, G. C., Segreti, A. C., Girgis, R. R., Seoane, F., Beaver, J. S., Duan, N., & Hosford, D. A. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.259 · Cited by 176 · see citing works

Development of nicotinic drug therapy for cognitive disorders

Levin, E. D., & Rezvani, A. H. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00885-7 · Cited by 176 · see citing works

Laminar distribution of nicotinic receptor subtypes in cortical regions in schizophrenia

Marutle, A., Zhang, X., Court, J., Piggott, M., Johnson, M., Perry, R., Perry, E., & Nordberg, A. (2001) · Journal of Chemical Neuroanatomy · doi:10.1016/s0891-0618(01)00117-x · Cited by 175 · see citing works

Nicotine and Behavioral Markers of Risk for Schizophrenia A Double-Blind, Placebo-Controlled, Cross-Over Study

Dépatie, L. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00372-x · Cited by 175 · see citing works

Neuronal nicotinic receptors: from structure to function

Bertrand, D. (2001) · Nicotine & Tobacco Research · doi:10.1080/14622200110050213 · Cited by 175 · see citing works

Identifying and treating cognitive impairment in bipolar disorder

Goldberg, J. F., & Chengappa, K. R. (2009) · Bipolar Disorders · doi:10.1111/j.1399-5618.2009.00716.x · Cited by 174 · see citing works

Nootropic α7 nicotinic receptor allosteric modulator derived from GABA A receptor modulators

Ng, H. J., Whittemore, E. R., Tran, M. B., Hogenkamp, D. J., Broide, R. S., Johnstone, T. B. C., Zheng, L., Stevens, K. E., & Gee, K. W. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701321104 · Cited by 171 · see citing works

Galantamine for the treatment of cognitive impairments in people with schizophrenia

Buchanan, R. W., Conley, R. R., Dickinson, D., Ball, M. P., Feldman, S., Gold, J. M., & McMahon, R. P. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.07050724 · Cited by 170 · see citing works

Recent Advances in the Development of Novel Pharmacological Agents for the Treatment of Cognitive Impairments in Schizophrenia

Buchanan, R. W., Freedman, R., Javitt, D. C., Abi‐Dargham, A., & Lieberman, J. A. (2007) · Schizophrenia Bulletin · doi:10.1093/schbul/sbm083 · Cited by 169 · see citing works

A double blind placebo controlled trial of donepezil adjunctive treatment to risperidone for the cognitive impairment of schizophrenia

Friedman, J. I., Adler, D. N., Howanitz, E. M., Harvey, P. D., Brenner, G. H., Temporini, H. D., WHITE, L. E., & Parrella, M. J. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01342-7 · Cited by 168 · see citing works

Downregulated Kynurenine 3-Monooxygenase Gene Expression and Enzyme Activity in Schizophrenia and Genetic Association With Schizophrenia Endophenotypes

Wonodi, I., Stine, O. C., Sathyasaikumar, K. V., Roberts, R. C., Mitchell, B. D., Hong, L. E., Kajii, Y., Thaker, G. K., & Schwarcz, R. M. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.71 · Cited by 166 · see citing works

A cog in cognition: How the α7 nicotinic acetylcholine receptor is geared towards improving cognitive deficits

Leiser, S. C., Bowlby, M. R., Comery, T. A., & Dunlop, J. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.03.009 · Cited by 166 · see citing works

Perinatal Choline Effects on Neonatal Pathophysiology Related to Later Schizophrenia Risk

Ross, R. G., Hunter, S. K., McCarthy, L., Beuler, J., Hutchison, A. K., Wagner, B. D., Leonard, S., Stevens, K. E., & Freedman, R. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.12070940 · Cited by 165 · see citing works

Nicotine, Brain Nicotinic Receptors, and Neuropsychiatric Disorders

Mihailescu, S., & Drucker-Colı́n, R. (2000) · Archives of Medical Research · doi:10.1016/s0188-4409(99)00087-9 · Cited by 162 · see citing works

Impaired performance of alpha7 nicotinic receptor knockout mice in the five-choice serial reaction time task

Hoyle, E., Genn, R. F., Fernandes, C., & Stolerman, I. P. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0549-2 · Cited by 161 · see citing works

Neuronal Nicotinic Receptor Subtypes

Lindstrom, J. M., Anand, R., Peng, X.-D., Gerzanich, V., Wang, F., & LI, Y. (1995) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1995.tb17467.x · Cited by 160 · see citing works

Nicotine binding in human striatum: elevation in schizophrenia and reductions in dementia with Lewy bodies, Parkinson’s disease and Alzheimer’s disease and in relation to neuroleptic medication

COURT, J. A., Piggott, M. A., Lloyd, S. R., Cookson, N., Ballard, C. G., McKeith, I. G., Perry, R. H., & Perry, E. K. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00071-3 · Cited by 156 · see citing works

Muscarinic and nicotinic receptors synergistically modulate working memory and attention in humans

Ellis, J. R., Ellis, K. A., Bartholomeusz, C. F., Harrison, B. J., Wesnes, K. A., Erskine, F. F., Vitetta, L., & Nathan, P. J. (2005) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145705005407 · Cited by 154 · see citing works

The genetics of sensory gating deficits in schizophrenia

Freedman, R., Olincy, A., Ross, R. G., Waldo, M. C., Stevens, K. E., Adler, L. E., & Leonard, S. (2003) · Current Psychiatry Reports · doi:10.1007/s11920-003-0032-2 · Cited by 153 · see citing works

Ultrastructural alterations in hippocampal mossy fiber synapses in schizophrenia: A postmortem morphometric study

Kolomeets, N. S., Orlovskaya, D. D., Rachmanova, V. I., & Uranova, N. A. (2005) · Synapse · doi:10.1002/syn.20153 · Cited by 149 · see citing works

Alternative phenotypes for the complex genetics of schizophrenia

Freedman, R., Adler, L. E., & Leonard, S. S. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00321-7 · Cited by 144 · see citing works

Efficacy and Safety of Donepezil in Patients with Schizophrenia or Schizoaffective Disorder: Significant Placebo/Practice Effects in a 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial

Keefe, R. S. E., Malhotra, A. K., Meltzer, H. Y., Kane, J. M., Buchanan, R. W., Murthy, A. K., Sovel, M., Li, C., & GOLDMAN, R. S. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301499 · Cited by 146 · see citing works

Effects of Moderate-Dose Treatment With Varenicline on Neurobiological and Cognitive Biomarkers in Smokers and Nonsmokers With Schizophrenia or Schizoaffective Disorder

Hong, L. E. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.83 · Cited by 150 · see citing works

Therapeutic Potential of α7 Nicotinic Acetylcholine Receptors

Bertrand, D., Lee, C., Flood, D. G., Marger, F., & Donnelly‐Roberts, D. L. (2015) · Pharmacological Reviews · doi:10.1124/pr.113.008581 · Cited by 139 · see citing works

Nonsynaptic Chemical Transmission Through Nicotinic Acetylcholine Receptors

Lendvai, B., & Vizi, E. S. (2008) · Physiological Reviews · doi:10.1152/physrev.00040.2006 · Cited by 137 · see citing works

Improvement in Smooth Pursuit Eye Movements after Cigarette Smoking in Schizophrenic Patients

D, A. O. M. (1998) · Neuropsychopharmacology · doi:10.1016/s0893-133x(97)00095-x · Cited by 136 · see citing works

Elementary phenotypes in the neurobiological and genetic study of schizophrenia

Adler, L. E., Freedman, R., Ross, R. G., D, A. O. M., & Waldo, M. C. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00085-2 · Cited by 136 · see citing works

Dopamine and nicotinic receptor binding and the levels of dopamine and homovanillic acid in human brain related to tobacco use

Court, J. A., Lloyd, S., Thomas, N., Piggott, M. A., Marshall, E. F., Morris, C. M., Lamb, H., Perry, R. H., Johnson, M., & Perry, E. K. (1998) · Neuroscience · doi:10.1016/s0306-4522(98)00088-8 · Cited by 135 · see citing works

Treating schizophrenia symptoms with an α7 nicotinic agonist, from mice to men

D, A. O. M., & Stevens, K. E. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.07.015 · Cited by 131 · see citing works

Subtypes of nicotinic acetylcholine receptors in nicotine reward, dependence, and withdrawal: evidence from genetically modified mice

Fowler, C. D., Arends, M. A., & Kenny, P. J. (2008) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32830c360e · Cited by 131 · see citing works

Genetics of Chromosome 15q13-q14 in Schizophrenia

Leonard, S. S., & Freedman, R. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.03.054 · Cited by 130 · see citing works

Nicotinic interactions with antipsychotic drugs, models of schizophrenia and impacts on cognitive function

Levin, E. D., & Rezvani, A. H. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.07.019 · Cited by 129 · see citing works

Current and Novel Approaches to the Drug Treatment of Schizophrenia

Rowley, M., Bristow, L. J., & Hutson, P. H. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm0002432 · Cited by 129 · see citing works

Schizophrenia and Nicotinic Receptors

Freedman, R., Adler, L. E., Bickford, P. C., Byerley, W., Coon, H. H., Cullum, C. M., Griffith, J. M., Harris, J. G., Leonard, S. S., Miller, C. L., et al. (1994) · Harvard Review of Psychiatry · doi:10.3109/10673229409017136 · Cited by 217 · see citing works

The α7-nicotinic acetylcholine receptor and the pathology of hippocampal interneurons in schizophrenia

Freedman, R., Adams, C. E., & Leonard, S. S. (2000) · Journal of Chemical Neuroanatomy · doi:10.1016/s0891-0618(00)00109-5 · Cited by 212 · see citing works

Nicotinic Receptor Function in Schizophrenia

Leonard, S. S., Adams, C., Breese, C. R., Adler, L. E., Bickford, P. C., Byerley, W., Coon, H. H., Griffith, J. M., Miller, C., Myles‐Worsley, M., et al. (1996) · Schizophrenia Bulletin · doi:10.1093/schbul/22.3.431 · Cited by 263 · see citing works

Nicotinic Receptors and the Pathophysiology of Schizophrenia

Freedman, R., Leonard, S. S., Adler, L. E., Bickford, P. C., Byerley, W., Coon, H. H., Miller, C., Luntz‐Leybman, V., Myles‐Worsley, M., Nagamoto, H. T., et al. (1995) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-7445-8_40 · Cited by 4 · see citing works

Nicotinic receptor desensitization and sensory gating deficits in schizophrenia

Griffith, J. M., O'Neill, J. E., Petty, F., Garver, D. L., Young, D. A., & Freedman, R. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(97)00362-4 · Cited by 109 · see citing works